Medivir licenses Respiratory Syncytial Virus drug program from Boehringer Ingelheim –

August 5, 2014 11:28 am

Leave a Reply

Your email address will not be published. Required fields are marked *


Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now